Summary The milk fat globule membrane antibodies HMFGI, HMFG2, NCRC 11 and four of the Mam 6 series, and the lectins peanut agglutinin, wheat germ agglutinin, Concanavalin A, Lotus tetragonolobus and Ulex europaeus I have been applied to 115 stage I and II breast carcinomas (median follow up = 36 months) to assess their value as prognostic markers. Of the milk fat globule membrane antibodies only NCRC 11 staining showed a relationship to development of recurrent disease and overall survival, but this did not act as an independent indicator over and above that provided by histological grade. None of the lectins gave prognostic information, including those whose binding related to node status or grade. It is concluded that for short-term prognosis none of the markers-can given independent prognostic information over and above that provided by histological evaluation.
The biological behaviour of breast carcinoma can vary considerably such that there are patients with a very poor prognosis (Blamey et al., 1979) and those who remain free from disease for over 20 years (Brinkley & Haybittle, 1975) . Factors such as the extent of spread (both nodal and distant) at the time of presentation are important in predicting behaviour, and this forms the basis of staging systems. However, changes in surgical practice with a reduction in axillary node sampling, plus a need to subdivide node negative early stage patients into poor or good risk categories means that there is a need to maximise the amount of prognostic information which can be obtained from the primary tumour.
The immunohistochemical assessment of primary tumours for the expression of various markers of potential prognostic value is one such approach. The use of antibodies to different components of the milk fat globule membrane has resulted in conflicting reports. Wilkinson et al. (1984) concluded that the antibody HMFG1 could be useful as a prognostic indicator, but Berry et al. (1985) found no relationship between the extent of staining with HMFG1 and HMFG2 and survival. Ellis et al. (1985 Ellis et al. ( , 1987 used the monoclonal antibody NCRC 11, which although raised against a breast carcinoma metastasis detects high molecular weight glycoproteins similar-to those recognised by antibodies raised against the milk fat globule membrane. They found a clear relationship between immunoreactivity of carcinomas and the clinical course of the disease. Angus et al. (1986) , however, using the same antibody, did not find a statistically significant relationship with prognosis. Direct comparison of the staining obtained with HMFG1, HMFG2 and NCRC 11 antibodies for the same group of carcinomas and their relationship to prognosis has not been published.
Another approach which has -been evaluated for its prognostic value has been the binding of lectins to primary tumours. Greater reactivity of carcinomas with Helix pomatia was reported as relating to poorer survival (Fenlon et al., 1987; Leathem & Brooks, 1987) as did Ulex europaeus I binding (Fenlon et al., 1987) .
In the present study a group of early (stage I and II) carcinomas have been studied for the expression of milk fat globule membrane antigens as determined by antibodies HMFG1, HMFG2, NCRC 11 and four against the Mam 6 antigen (Hilkens et al., 1984) , and for binding of the lectins Concanavalin A, peanut agglutinin, wheat germ agglutinin, Lotus tetragonolobus and Ulex europaeus I (Walker, 1983 (Walker, , 1984a (Walker, ,b, 1985 , and the findings related to short-term recurrence and survival. The primary treatment for the majority -of patients was mastectomy with axillary dissection. A small number underwent lumpectomy and radiotherapy, with axiilary node sampling. All patients with axillary lymph node metastasis received a course of radiotherapy. A small number (< 10) were given adjuvant chemotherapy. Clinical follow-up was from 12 to 82 months with a median follow-up period of 36 months.
Tissues and histology
All cases were received immediately after resection. Samples from each were frozen in isopentane cooled in liquid nitrogen, and stored in liquid nitrogen vapour phase. A parallel block was fixed in 4% formaldehyde in saline for 18-36 h and processed through to paraffin wax.
Haematoxylin and eosin stained sections were examined for classification using WHO criteria, and graded for differentiation using a modification of the Broom & Richardson grading system (Elston, 1987 Controls were the omission of the primary antibody.
Lectin histochemistry
The methods for this have been described previously (Walker, 1983 (Walker, , 1984a (Walker, ,b, 1985 and Lotus tetragonolobus-peroxidase (30 yg ml-') for 60 min, followed by development of the peroxidase.
Controls for each lectin were absorption with 0.1 M appropriate and inappropriate sugars.
Assessment
Antibodies The proportion of cells reacting with HMFGI and HMFG2 was quantified by cell counting, fields being selected at random but with representative assessment of the whole section. The extent of staining was divided into four categories: negative; less than 30% (few); 30-60% (moderate); more than 60% (many). In general, counts were less than 20%, between 40 and 50% and clearly above 60%. For a group of 30 carcinomas cell counting was repeated using a Kontron Messgerte GMBH Videoplan, as described previously (Jones & Walker, 1987) , and good reproducibility was demonstrated. Localisation of staining, e.g. extra or intracellular, and intensity of staining were not assessed.
A similar method was used for assessing NCRC 11 and Mam 6 staining, but the extent of staining was categorised as: negative; less than 25%; 25-50%; 50-75%; and greater than 75%. Intra-observer variation was assessed by performing a second assessment at least four months after the first one, and without knowledge of the first score, and was found to be less than 5%. Lectins Assessment was as described previously (Walker 1983 (Walker , 1984a (Walker ,b, 1985 It was evident that there were quite marked variations in the extent of reactivity with the milk fat globule membrane antibodies, both within individual tumours and overall. Only the two fucose-specific lectins could be compared, and the differences in the extent of binding reflected that previously observed (Walker, 1984c (Walker, 1983 (Walker, , 1984a (Walker, , b, 1985 , (Figure 1 ). There was no relationship between node status and development of recurrent Figure 2 Actuarial curve for overall survival in relation to staining with NCRC 11, 50% of cells positive being the cut-off point (0.05 > P> 0.02).
Discussion
Several studies have been reported which assess the value of using monoclonal antibodies and lectin binding to determine the behaviour of breast carcinomas (Wilkinson et al., 1984; Berry et al., 1985; Rasmussen et al., 1985; Ellis et al., 1987; Fenlon et al., 1987; Leatham & Brooks, 1987) . The present study differs in applying a wide range of markers to the same group of early breast carcinomas and has found that the majority show no relationship to patient outcome and that the one that does is not an independent predictor. The number included in the study are smaller than some series e.g. that of Ellis et al. (1987) but are comparable to others (Berry et al., 1985) . The period of follow-up is also shorter than that of Ellis et al. (1987) but is similar to other studies. Receptor status data, considered by several groups, was not available for all tumours, so was not included.
Node status was not as prognostically significant as would be expected (Fisher et al., 1975; Blamey et al., 1979) . This may be due to the shorter period of follow-up than that considered in other studies. Histological grading proved to be of prognostic value, as reported by others (Elston et al., 1982; Contesso et al., 1989) .
Previous assessments of the milk fat globule membrane antibodies HMFGI and HMFG2 have differed in their conclusions. Wilkinson et al. (1984) considered that the localisation as well as the extent of staining with HMFGI was important as a prognostic indicator. This was not included in the categorisation of staining patterns in the present study but was by Berry et al. (1985) , yet neither study found a relationship between HMFGI and prognosis. The antigen recognised by HMFGI has a relationship to functional differentiation in that tumours with >20% of cells expressing it are more likely to respond to endocrine therapy (Baildam et al., 1988) and contain oestrogen and progesterone receptor (Baildam et al., 1989) . While no significant relationship to structural differentiation was recognised in the present study, this may be due to different cut-off points for extent of expression. HMFG2 staining patterns are again shown to be of no prognostic value.
The only marker which showed any relationship to development of recurrent disease and survival was NCRC 11, when assessed by life table analysis, which concurs with the findings of Ellis et al. (1987) but not those of Angus et al. (1986) . However, multivariate analysis showed that in this series it did not act as an independent prognostic indicator, as previously reported, because of the close relationship between staining and histological grade. The latter relationship has also been shown by Ellis et al. Rasmussen et al. (1985) noted that staining with the milk fat globule membrane antibody Mam 3b gave prognostic information but that there was no improvement in prediction of recurrence over that given by standard methods. As indicated above, the duration of follow-up in the present study is shorter than the study of Ellis et al. It will be of interest to see whether there is any change in the significance of NCRC 11 as a predictor when the patients are followed for a longer time period.
The series of antibodies directed against Mam 6 have not previously been evaluated for prognostic value but none showed any relationship. This group of antibodies (Hilkens et al., 1984) like HMFG1 and 2 (Taylor-Papadimitriou et al., 1981) were raised against the milk fat globule membrane, whereas NCRC 11 was generated against a membrane fraction of a breast carcinoma metastasis (Ellis et al., 1984) . All detect antigenic sites on polymorphic epithelial nuclei (PEM) (Hilkens, 1988) . The differences in the frequency of staining patterns within and between carcinomas, and in their relationships to differentiation and behaviour, reflect the complex glycosylated nature and the physical structure of PEM. It is of interest that NCRC 11 should behave differently from the other antibodies since it detects glycoproteins of a similar molecular weight to other milk fat globule membrane antibodies (Griffiths et al., 1987) .
Lectins bind to specific sugar groups, but these can be common to several glycoproteins present within the same cell or tissue. Other problems in using and interpreting lectin binding is that minor variations in the composition of oligosaccharide chains, not necessarily involving the lectinspecific sugars, can affect binding. Such micro-heterogeneity is more frequent in carcinomas (Ogata et al., 1976) . It is therefore not surprising that lectin binding has not proved to be of short-term prognostic value. Fenlon et al. (1987) considered Ulex europaeus I staining to relate to disease-free interval and survival but studied patients with a longer period of follow-up. Leatham & Brooks (1987) found Helix pomatia binding to be of predictive value in premenopausal but not post-menopausal women. Evaluation of a larger series than the present one would be required to confirm or refute their findings.
The assessment of histological grade has been criticised because of its subjective nature (Stenkvist et al., 1979) . There can also be many problems in using immunohistochemistry as a prognostic tool. Factors which can effect findings and make comparability between laboratories difficult are: the effect of fixation; the sensitivity of the methods used; and the methods of assessment of staining. From this study of markers in relation to short-term prognosis none have been found which can give independent prognostic information over and above that which can be obtained from a haematoxylin and eosin stained section. Evaluation of the data after a longer period of follow-up will be of interest to assess whether the same conclusion applies.
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